Abstract:Objective: To separately compare the long-term risk of mortality among bariatric surgical patients undergoing either Roux-en-Y gastric bypass (RYGB) or sleeve gastrectomy (SG) to large, matched, population-based cohorts of patients with severe obesity who did not undergo surgery. Background: Bariatric surgery has been associated with reduced long-term mortality compared to usual care for severe obesity which is particularly relevant in the COVID-19 era. Most prior studies involved the RYGB operation and there is less long-term data on the SG. Methods: In this retrospective, matched cohort study, patients with a body mass index ≥35 kg/m 2 who underwent bariatric surgery from January 2005 to September 2015 in three integrated health systems in the United States were matched to nonsurgical patients on site, age, sex, body mass index, diabetes status, insulin use, race/ethnicity, combined Charlson/Elixhauser comorbidity score, and prior health care utilization, with follow-up through September 2015. Each procedure (RYGB, SG) was compared to its own control group and the two surgical procedures were not directly compared to each other. Multivariable-adjusted Cox regression analysis investigated time to all-cause mortality (primary outcome) comparing each of the bariatric procedures to usual care. Secondary outcomes separately examined the incidence of cardiovascular-related death, cancer related-death, and diabetes related-death. Results: Among 13,900 SG, 17,258 RYGB, and 87,965 nonsurgical patients, the 5-year follow-up rate was 70.9%, 72.0%, and 64.5%, respectively. RYGB and SG were each associated with a significantly lower risk of all-cause mortality compared to nonsurgical patients at 5-years of follow-up (RYGB: HR = 0.43; 95% CI: 0.35,0.54; SG: HR = 0.28; 95% CI: 0.13,0.57) Similarly, RYGB was associated with a significantly lower 5-year risk of cardiovascular-(HR = 0.27; 95% CI: 0.20, 0.37), cancer- (HR = 0.54; 95% CI: 0.39, 0.76), and diabetes-related mortality (HR = 0.23; 95% CI:0.15, 0.36). There was not enough follow-up time to assess 5-year cause-specific mortality in SG patients, but at 3-years follow-up, there was significantly lower risk of cardiovascular- (HR = 0.33; 95% CI:0.19, 0.58), cancer- (HR = 0.26; 95% CI:0.11, 0.59), and diabetes-related (HR = 0.15; 95% CI:0.04, 0.53) mortality for SG patients. Conclusion: This study confirms and extends prior findings of an association with better survival following bariatric surgery in RYGB patients compared to controls and separately demonstrates that the SG operation also appears to be associated with lower mortality compared to matched control patients with severe obesity that received usual care. These results help to inform the tradeoffs between long-term benefits and risks of bariatric surgery.

Impact of COVID-19 Pandemic on Adolescents Undergoing Metabolic Bariatric Surgery

The Impact of COVID-19 Pandemic on Patient Selection and Access to Care, Approach Type, and Postoperative Outcomes in Bariatric Surgery

The Impact of the COVID-19 Pandemic on Bariatric Surgery: Results from a Worldwide Survey

Bariatric surgery and COVID-19 outcomes: Results from the PaTH to Health Diabetes Study

Impact of the COVID-19 Lockdown on Primary Bariatric Surgery: A Comparative Study of Weight Loss Trajectories and Perioperative Outcomes

A systematic review and meta‐analysis combing adolescent and adult data to evaluate weight loss and the effect of age following the laparoscopic sleeve gastrectomy

Effect of COVID-19 changes on outcomes and socioeconomic disparities following metabolic and bariatric surgery

Evaluating Safety and Durability of Adolescent Metabolic and Bariatric Surgery

Presurgery health influences outcomes following vertical sleeve gastrectomy in adolescents

Metabolic and Bariatric Surgery for Adolescents

Effects of COVID-19 lockdown on a bariatric surgery waiting list cohort and its influence in surgical risk perception

Psychosocial Outcomes after Adolescent Metabolic and Bariatric Surgery: A Narrative Review of the Literature

Clinical characteristics of coronavirus disease 2019 in patients undergoing laparoscopic bariatric/metabolic surgery: a nationwide survey in Japan

Metabolic and bariatric surgery outcomes in adolescents: a single center's seven-year update

Outcomes after metabolic and bariatric surgery in preteens versus teens using the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program database and center-specific data

Reduction in Long-term Mortality After Sleeve Gastrectomy and Gastric Bypass Compared to Nonsurgical Patients With Severe Obesity

Impact of age on morbidity and mortality following bariatric surgery

Systematic review of psychological and social outcomes of adolescents undergoing bariatric surgery, and predictors of success

The psychological impact of COVID-19 pandemic on patients included in a bariatric surgery program

Adolescent Bariatric Surgery: Effects of Socioeconomic, Demographic, and Hospital Characteristics on Cost, Length of Stay, and Type of Procedure Performed

Comparative outcomes of laparoscopic adjustable gastric banding in adolescents and adults